In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Corcept Therapeutics Inc (NASDAQ: CORT) closed at $75.80 in the last session, down -0.55% from day before closing price of $76.22. In other words, the price has decreased by -$0.55 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
We take a closer look at CORT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.37. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Guyer William sold 32,262 shares for $74.17 per share. The transaction valued at 2,393,014 led to the insider holds 5,487 shares of the business.
MAHONEY DAVID L sold 27,352 shares of CORT for $2,030,452 on May 16 ’25. The Director now owns 0 shares after completing the transaction at $74.23 per share. On May 20 ’25, another insider, Robb Gary Charles, who serves as the Officer of the company, bought 2,279 shares for $75.85 each.
Valuation Measures:
As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.79, and their Forward P/E ratio for the next fiscal year is 28.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.73 while its Price-to-Book (P/B) ratio in mrq is 11.76.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $117.33, while it has fallen to a 52-week low of $27.30. The 50-Day Moving Average of the stock is 9.89%, while the 200-Day Moving Average is calculated to be 36.93%.
Shares Statistics:
A total of 105.98M shares are outstanding, with a floating share count of 93.74M. Insiders hold about 11.60% of the company’s shares, while institutions hold 78.97% stake in the company.
